Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Innovative Healthcare Institute
2019-08-01
|
| Series: | Journal of Immunotherapy and Precision Oncology |
| Online Access: | https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_15_19 |
| _version_ | 1797962694508150784 |
|---|---|
| author | Joud Hajjar |
| author_facet | Joud Hajjar |
| author_sort | Joud Hajjar |
| collection | DOAJ |
| first_indexed | 2024-04-11T01:16:55Z |
| format | Article |
| id | doaj.art-082639d640434c379dd0205883041936 |
| institution | Directory Open Access Journal |
| issn | 2666-2345 2590-017X |
| language | English |
| last_indexed | 2024-04-11T01:16:55Z |
| publishDate | 2019-08-01 |
| publisher | Innovative Healthcare Institute |
| record_format | Article |
| series | Journal of Immunotherapy and Precision Oncology |
| spelling | doaj.art-082639d640434c379dd02058830419362023-01-03T19:14:19ZengInnovative Healthcare InstituteJournal of Immunotherapy and Precision Oncology2666-23452590-017X2019-08-01535410.4103/JIPO.JIPO_15_19i2590-017X-2-3-53Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and EfficacyJoud Hajjarhttps://jipo.org/doi/pdf/10.4103/JIPO.JIPO_15_19 |
| spellingShingle | Joud Hajjar Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy Journal of Immunotherapy and Precision Oncology |
| title | Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy |
| title_full | Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy |
| title_fullStr | Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy |
| title_full_unstemmed | Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy |
| title_short | Cancer Immunotherapy for the Immunosuppressed: Dissecting the Conundrum of Safety and Efficacy |
| title_sort | cancer immunotherapy for the immunosuppressed dissecting the conundrum of safety and efficacy |
| url | https://jipo.org/doi/pdf/10.4103/JIPO.JIPO_15_19 |
| work_keys_str_mv | AT joudhajjar cancerimmunotherapyfortheimmunosuppresseddissectingtheconundrumofsafetyandefficacy |